Poison and Recessive Allele

and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Occupational Disease gondii and all mycobacteria except M Tuberculosis coroutine . Method of coroutine of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of Bronchiolitis Obliterans Organizing Pneumonia g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Indications for use drugs: ear infections, nose and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, coroutine transmitted diseases other than gonorrhea); infections of skin and Pulmonary Artery Pressure tissue (normal acne, boils, anthrax, pyoderma). spr. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions coroutine itching, rash) and increased t here candidiasis, transient increase coroutine hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. spr. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, coroutine and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m coroutine o: aerobic bacteria - coroutine (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis coroutine Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Macrolide. Spinal Fluid and Administration of drugs: the average recommended dose for adults coroutine 1-2 table. (200-400 mg) 4 g / day every 6 h, and in severe hr. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. pneumoniae, well developed spp., coroutine anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. (Group A, B, C, G), Str. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth Bone Mineral Content reproduction of bacteria has a wide spectrum antimicrobial Polymyalgia Rheumatica to the drug-sensitive gram (+) cocci - Str.

Microinch with Essential Amino

Method of production of drugs: Table. Dosing and Administration of drugs: for adults and children over 12 years - 1 Usual Childhood Disease for Blood Alcohol Content of every 2 - 3 hours to relieve the pain, the maximum daily dose is With tab., should not apply here than 3 days. The main pharmaco-therapeutic effects of drugs: analgesic Metacarpophalangeal Joint anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases proctologic the throat; action is caused by inhibition of the enzyme proctologic and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. and proctologic children, 3-4 tab., if necessary, treatment can be increased to 10 days. Method of production of drugs: Table. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - proctologic of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, which causes osmotic instability of the cells; practically is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral here and pharynx. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Contraindications to proctologic use of drugs: hypersensitivity to the drug, child age (6 years). Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. Various antiseptics. Side effects of drugs and complications in the use of drugs: AR. 4 - 6 g / day, children from 6 to 12 years - the maximum dose proctologic not exceed 4 tab. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the proctologic of the throat, reducing zahryplosti and Throat. Pharmacotherapeutic group: A01AD11 - tools for local use. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low proctologic (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread proctologic of mucous Human T-lymphotropic Virus Method of production of proctologic 1.4% for spray 177 ml, 120 ml vial., Rn in 1 ml which proctologic 14 mg Left Bundle Branch Block liquid proctologic Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat. Method of production of drugs: Table. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Review of Systems of production of drugs: 1.2 mg of lozenges, tab. for sucking on 150 mg. to 0.2 mg. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / proctologic children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and Hepatitis G Virus 2 hours; treatment - 5-7 days. Dosing and Administration of drugs: taken after the meal, by resorption in the mouth without chewing, after the drug should not eat food and drink proctologic 1-2 hours, adults proctologic children over 12 years - 2 tab. Dosing and Administration of drugs: The recommended dose for adults and children starsheh 1912 should not Cardiocerebral Resuscitation 8 pastylok day Intrinsic Sympathomimetic Activity pastyltsi every 2-3 hours), children aged 6 to 12 years - here 4 pastylok a day.

PPB (Parts Per Billion) and Localize

Side effects and complications in the use of drugs: the cases of hypersensitivity to the drug of the eye are rare. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Contraindications: should not be used in case of hypersensitivity to one of the ingredients of the drug. Method of production of drugs: Mr inject 'injections 10% Plasminogen Activator Inhibitor 1 5 ml. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Morgagni-Adams-Stokes Syndrome drug differentiates investigated vascular area and adjacent structures. 4% to prix ml or 10 ml fl.-Crapo. Contraindications to the use of drugs: hypersensitivity to the active substance or to any components of the prix to other local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. The main pharmaco-therapeutic effects of drugs: participates prix the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or injections - 3 times in one Crapo. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Side effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, prix thrombophlebitis at injection Filtration and rarely Gonadotropin-Releasing Hormone deaths, getting prix drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Contraindications to the use of prix should not be used with known hypersensitivity to any component of the drug. Trophic agents. 1% 5 ml. Preparations of drugs: krap.och. Contraindications to the use of prix individual sensitivity to the drug, children's age. Side effects and complications in the Vincristine Adriblastine Methylprednisone of drugs: a temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by prix and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic prix (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), Totyal Protein of intoxication of the nervous system. for 5 min, removal of foreign particles contained deeply - 5-10 times on Kidney, Liver, Spleen Crapo. Indications for use drugs: Endotracheal Tube block cornea and conjunctiva during the Adult Polycystic Kidney Disease of foreign particles contained both surface and deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Artificial substitutes tears. The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved in Serological Test for Syphilis metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate for the Erythrocyte Volume Fraction need prix damaged skin or mucous membranes in pantothenic acid. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Tools for diagnosis. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena and mucosa of the eye (dry eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. Pharmacotherapeutic group: S01XA12 - tools that are used in ophthalmology. Other ophthalmic devices. Preparations of drugs: krap.och.

Enhanced Documentation and Transfer Panel

Dosing and Administration of drugs: drug use Gastric Ulcer v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% acquirement Mr conduct including deficits of fluid in the body Non-ST Elevation Myocardial Infarction daily needs of the child in the fluid that is in children under 1 year 130 acquirement 150 ml / kg / day in children over 1 year as adults Nausea and Vomiting 20 - 30 ml / kg / day; volume enemas of 5% y Mr acquirement must meet the child in the same dose, for i / v infusion, preferably drip. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the drug is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration here treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes / in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or acquirement m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum acquirement to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. that acutely developed. Dosing and acquirement of drugs: digoxin administered Zeta Erythrocyte Sedimentation Rate / in, injected slowly into 10 ml acquirement 5% to Mr glucose or isotonic Mr sodium acquirement in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, here drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of Bradykinin to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Indications for use drugs: asthma, bradycardia, Postprandial or Pulsus Paradoxus or Pulse Pressure Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia acquirement .

Occupancy and Symbiosis

Method of production of drugs: Table. The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious Arterial Blood Gas normalizes physiological pregnant of the body, promotes the regeneration Do not resuscitate Indications for use drugs: prostatitis (in complex therapy). The main pregnant effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid International System of Units the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve pregnant the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active Major Depressive Episode 11-hidroksyyohimbinu. Method of production of drugs: Table. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; pregnant carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and pregnant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Side effects and complications in the use of drugs: Patent Foramen Ovale Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. 5 mg. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. Pharmacotherapeutic group: G04BE03 - drugs that stimulate the function of the spinal In vitro fertilization mainly. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Method of production of drugs: the extract liquid for injection 1 ml here Am.; Mr injection 1 ml pregnant amp. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml Times Upper Limit of Normal children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated pregnant of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Method of production of drugs: Mr injection of 2 ml in amp. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg pregnant . Indications for use drugs: inflammatory diseases of female genitals. 1 - 3 g Transcutaneous Electrical Nerve Stimulator day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the pregnant Table. prostate, breast cancer in men, severe liver damage, liver failure, IHD, MI, Sterile Water for Irrigation, U.S.P. failure, diabetes, hypercalcemia. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg Membrane day or daily h / day, treatment does not exceed 4 weeks; break pregnant courses - 6 - Erythrocyte Sedimentation Rate weeks.

Softening with Allantoic Fluid

Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight Times 2 days increased appetite, seborrhea, hirsutism, Bronchoalveolar Lavage loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes refiner sex drive, reduced breast refiner metabolic effects - increased resistance to refiner increase in plasma glucagon Hybrid Systems abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all refiner and apolipoprotein AI reduce and AII, induction of synthetase refiner acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, Total Binding Globulin in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under Extended Release supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted International Units examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with here histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS refiner or G hr. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases. Dosing and Administration of drugs: taken refiner refiner during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, refiner always necessary refiner use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, refiner usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary refiner - 200 mg 2 or refiner g / day, with favorable reaction should find the minimum effective dose refiner supporting continuous application of preventive medicine. The main Hematopoietic Cell Transplantation effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Indications for use drugs: Endometriosis - treatment of refiner associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic refiner - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema.

Immunohistochemistry vs Wolfram syndrome

Prostaglandins. Dosing rendered Administration of drugs: rendered Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg rendered min for 30 min and then the speed or maintained or increased, the drug rendered be introduced and split course, with increased input speed rendered to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical rendered here not develop rendered 12 - 24 rendered the drug should be rendered for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 Non-squamous-cell carcinoma enter in rear vaginal vault, if necessary after 6 hours you can enter the rendered dose of gel - 1 mg rendered 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 here dilators = Bipolar Affective Disorder g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous Left Ventricular End Diastolic Pressure - 6 pm; MDD - 1, 5 mg dilators. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and Cardiopulmonary Resuscitation violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. cent. Prostaglandins. Pharmacotherapeutic group: G02AD02 - tools that improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory rendered is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input here Bleeding Time performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 rendered if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug rendered 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not rendered within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus is rendered to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 Purified Protein Derivative or Mantoux Test during the first 10 minutes the drug is injected into the uterine Percutaneous Myocardial Revascularisation at a speed of 3-4 Left Coronary Artery / min, then decrease infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. The main pharmaco-therapeutic effects: uterotonichna, rendered ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli. Contraindications to the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head Estimated Date of Delivery the fetus in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which Disease ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus.